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Polymorphisms in JMJD1C are 
associated with pubertal onset in 
boys and reproductive function in 
men
Nina Mørup, Alexander Siegfried Busch, Anne Kirstine Bang, Loa Nordkap, John E. Nielsen, 
Ewa Rajpert-De Meyts  , Anders Juul, Niels Jørgensen & Kristian Almstrup  
JMJD1C, a member of the Jumonji-domain containing histone demethylases protein family, has been 
associated with levels of sex-hormone binding globulin (SHBG) and testosterone in men, and knock-out 
rodent models show age-dependent infertility. The objective of this study was to investigate whether 
single nucleotide polymorphisms (SNPs) nearby JMJD1C are associated with pubertal onset in boys and 
with male reproduction. 671 peri-pubertal boys, 1,027 young men, 315 fertile men, and 252 infertile 
men were genotyped for two JMJD1C SNPs (rs7910927 and rs10822184). rs7910927 and rs10822184 
showed high linkage. Boys with the rs7910927 TT genotype entered puberty 3.6 months earlier than 
their peers (p = 2.5 × 10−2). In young men, the number of T alleles was associated with decreased levels 
of SHBG, follicle-stimulating hormone (FSH), testosterone, and testosterone x luteinizing hormone, as 
well as increased levels of Inhibin B, Inhibin B/FSH ratio, and testis size. No significant associations with 
semen parameters were observed and the genotype distribution was comparable among fertile and 
infertile men. In conclusion, genetic variation in the vicinity of JMJD1C had a surprisingly large impact 
on the age at pubertal onset in boys as well as levels of reproductive hormones and testis size in men, 
emphasizing the relationship between JMJD1C and reproductive functions.
Male reproduction is a strictly regulated process. The process relies on proper testicular development and hor-
monal feedback loops that have to be well-balanced for optimal reproductive function. Numerous factors can 
influence the reproductive capacity of men including life style factors, endocrine disrupting chemicals and 
genetic and epigenetic factors1. Recent genome-wide association studies (GWAS) with focus on reproductive 
hormones, such as Sex Hormone-Binding Globulin (SHBG)2 and testosterone (T)3 in men, have revealed asso-
ciations with two single nucleotide polymorphisms (SNPs) (rs7910927 and rs10822184, respectively) within or 
in close proximity to the jumonji domain-containing 1 C (JMJD1C) gene. JMJD1C is named after its Jumonji 
C (JmjC) domain, which is a hallmark of a large family of histone demethylases, where JMJD1C belongs to the 
lysine-specific demethylase 3 (KDM3) subfamily of Jumonji-domain containing proteins (reviewed in Johansson 
et al.4). However, the demethylase activity of JMJD1C has been disputed. Some researchers demonstrated its 
predicted enzymatic activity5 while others have been unable to reproduce this6. JMJD1C may possess other func-
tions that act independently of its JmjC domain. It has been found to interact with and function as a coactivator 
of the androgen receptor (AR) in humans7 and with the thyroid hormone receptor (TR) in yeast8. Consequently, 
JMJD1C may function at several levels by regulating epigenetic patterns and by being a coactivator of principal 
reproductive hormone receptors.
In rodent testes, JMJD1C is mainly found in undifferentiated spermatogonia9. Jmjd1c knock-out mice exhib-
ited age-dependent infertility, as they became infertile after 3 months of age due to progressive loss of germ cells. 
The same study showed that female mice deficient of Jmjd1c were not affected, and both serum testosterone and 
androstenedione levels were normal9. Another study used the Leydig cell line TM3 from mice to demonstrate 
that JMJD1C together with Steroidogenic Factor 1 bind to response elements in the promoter region of Cyp17a1 
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and induce gene transcription5. CYP17A1 acts upstream of testosterone in the steroidogenesis pathway where it 
facilitates conversion of pregnenolone and progesterone to DHEA and androstenedione, respectively. In rodents, 
members of the KDM3 family may functionally compensate for each other in a different way from humans, 
although several studies have suggested important reproductive functions in humans too. Also, large GWAS 
have identified several SNPs in JmjC-domain containing loci associated with age at menarche in girls10 and type 
2 diabetes in adult men and women11.
Here, we report an in-depth analysis of the association between two JMJD1C SNPs (rs7910927 and 
rs10822184) and male reproductive parameters in several well-characterized Danish cohorts of peri-pubertal 
boys, young men from the general population, and fertile and infertile men. We show that the two JMJD1C SNPs 
are not only significantly associated with circulating levels of SHBG and testosterone in accordance with previous 
studies, but also with age at pubertal onset in boys as well as testicular volume and levels of FSH and Inhibin B in 
young men.
Results
Genotype frequencies. The two JMJD1C SNPs rs7910927 and rs10822184 (Supplementary Fig. S1A) 
were found to be in linkage among the cohort of 671 boys from the COPENHAGEN Puberty Study (D′ = 0.97 
and R2 = 0.91) as well as among the young men (D′: 0.99 and R2 = 0.90, Table 1 and Supplementary Table S1). 
Consequently, data from one of the SNPs is very likely to yield similar associations as the other. We did not 
calculate the linkage in the smaller cohorts of fertile and infertile men, since they were only genotyped for the 
rs7910927 SNP. The allele frequencies of the two SNPs in the cohort of young men were 0.501 for G and 0.499 
for T (rs7910927) and 0.521 for C and 0.479 for T (rs10822184). The distribution of the genotypes in the adult 
cohorts is outlined in Table 1 together with median values of anthropometric and reproductive parameters.
Association with pubertal onset. We investigated the possible effect of the JMJD1C SNPs rs7910927 and 
rs10822184 on pubertal timing assessed by testicular growth in boys from the COPENHAGEN Puberty Study. 
We found a significant association (p = 0.025) between age at pubertal onset and rs7910927 in a recessive model 
(Fig. 1) but no significant association with rs10822184. Boys with the rs7910927 TT genotype entered puberty at 
an age of 11.5 years, which was 3.6 months earlier than boys with the TG or GG genotypes.
Association with reproductive parameters in young men. Both JMJD1C SNPs were found to be 
significantly associated with levels of SHBG (p = 1.02 × 10−8 (rs7910927); p = 2.0 × 10−7 (rs10822184), Fig. 2d, 
Table 2, and Supplementary Fig. S2) and total T (p = 1.19 × 10−3 (rs7910927) and p = 5.4 × 10−4 (rs10822184), 
Fig. 2e, Table 2, and Supplementary Fig. S2) in young men from the general Danish population. The levels of 
SHBG and T decreased with increasing numbers of the minor alleles (T) of both variants. In addition, both 
SNPs were found to be significantly associated with levels of FSH (p = 9.89 × 10−3 (rs7910927) and p = 1.5 × 10−3 
(rs10822184), Fig. 2a, Table 2, and Supplementary Fig. S2) with decreasing levels of FSH as a function of increasing 
number of minor alleles (T). Both SNPs were also significantly associated with levels of Inhibin B (p = 5.2 × 10−2 
(rs7910927) (not significant after log-transformation) and p = 2.0 × 10−2 (rs10822184), Fig. 2b, Table 2, 
and Supplementary Figure S2), with increasing inhibin B levels as a function of increasing number of minor 
alleles. No significant associations were observed with Luteinizing hormone (LH) or Estradiol levels (Table 2). 
Young men Fertile Infertile
rs7910927 GG 263 (25.7) 88 (27.9) 68 (27.0)
rs7910927 TG 498 (48.7) 167 (53.0) 119 (47.2)
rs7910927 TT 262 (25.6) 60 (19.0) 65 (25.8)
rs10822184 CC 287 (28.1) — —
rs10822184 CT 491 (48.0) — —
rs10822184 TT 244 (23.9) — —
Median Age (Years) 19.0 (17.8–29.1) 31.7 (22.0–43.7) 34.0 (19.6–56.0)
Median BMI (kg/m2) 22.2 (16.0–36.5) 23.9 (16.8–45.6) 25.0 (17.0–42.0)
Median Semen Volume (mL) 3.4 (0.5–11.2) 3.6 (0.7–11.4) 3.5 (0.9–9.8)
Median Sperm Concentration (million/mL) 44.0 (0–359) 61.3 (0.9–380) 9.9(0–187)
Median Total Sperm Count (million) 141.1 (0–1377) 230.0 (5.6–1215) 34.9 (0–806)
Median Morphologically normal sperm (%) 6.5 (0–76.0) 11.0 (0–48.0) 2.5 (0–14.5)
Median Motile sperm (AB) (%) 56.3 (0–89.3) 55 (5.3–83.7) 30.0 (0–84.0)
Median Testosterone (nmol/L) 21.0 (6.3–64.1) 17.2 (7.0–35.8) 17.8 (4.1–48.2)
Median FSH (U/L) 2.7 (0.4–16.5) 3.1 (0.6–19.0) 4.8 (0.6–61.0)
Median LH (nmol/L) 3.6 (0.7–11.6) 3.2 (0.8–8.8) 3.7 (0.9–27.3)
Median Testis Size (orchidometer) (mL) 20.0 (7.0–35.0) 22.5 (7.5–37.5) 18.0 (5.0–30.0)
Median Testis Size (ultrasound) (mL) 13.3 (3.3–31.8) 14.8 (7.5–37.5) 12.0 (1.5–26.5)
Table 1. Cohort information. For genotypes, the numbers depict the number of men with each genotype and 
the percentage in parentheses. For the other measures, the values are median values with lower and upper limits 
in parentheses.
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In summary, men with the TT genotype (for both SNPs) had significantly lower T, SHBG and FSH levels but 
higher Inhibin B levels (only significant for rs10822184) (Table 2).
The ratio of Inhibin B and FSH as well as the ratio of T and LH reflects the efficiency of the feedback loop 
between the gonads and the pituitary gland. We found significant associations between the two SNPs and 
the Inhibin B/FSH ratio (p = 1.54 × 10−2 (rs7910927) and p = 1.9 × 10−2 (rs10822184), Fig. 2c, Table 2, and 
Supplementary Fig. S2), reflecting an association with Sertoli cell function. Men with the TT genotype (of both 
SNPs) had a higher Inhibin B/FSH ratio indicating a better Sertoli cell function or ability to respond to FSH stim-
uli. No significant differences were found for the T/LH ratio (reflecting Leydig cell function) or the T/Estradiol 
ratio (a proxy for aromatase activity) (Table 2). However, both JMJD1C SNPs were significantly associated with 
T x LH (p = 4.3 × 10−3 (rs7910927) and p = 7.5 × 10−4 (rs10822184), Fig. 2f, Table 2, and Supplementary Fig. S2), 
where men with the TT genotype had lower T x LH compared to men with the other genotypes (for both JMJD1C 
SNPs).
We did not find any significant associations of semen parameters with the JMJD1C SNPs, although there 
was a tendency that men with the TT genotype had higher sperm concentration and higher total sperm count 
compared to men with other genotypes (for both JMJD1C SNPs, Fig. 2h, Table 2, and Supplementary Fig. S2). 
However, we detected a significant association between the JMJD1C SNPs and testicular volume (p-values for tes-
tis volume measured by ultrasound: 2.55 × 10−2 (rs7910927) and 2.4 × 10−2 (rs10822184)) (Fig. 2g, Table 2, and 
Supplementary Fig. S2) where the testis size increased with increasing numbers of minor alleles (T). Men with the 
TT genotype of both JMJD1C SNPs had significantly larger testes (approximately 1 ml) (Table 2).
Genotype frequencies among fertile and infertile men and associations with reproductive 
parameters. We investigated the frequency of one of the JMJD1C SNPs (rs7910927) in two other adult 
cohorts representing infertile (n = 252) and fertile men (n = 315). The distribution of genotypes is listed in 
Table 1. A chi-squared test revealed no significant differences in genotype frequencies when comparing each 
of the groups to the young men representing the general population. Moreover, no significant differences were 
found when fertile men were compared to infertile men. Among the fertile men, but not the infertile men, we 
found a significant association between the rs7910927 SNP and estradiol levels (see Supplementary Table S2 and 
S3). Similar, but non-significant, effects on reproductive hormone levels as observed with the young men, was 
observed among the fertile men (Table 2 and Supplementary Table S2). However, the tendencies differed among 
the infertile men where men with the TG genotype (rs7910927) had highest FSH, lowest Inhibin B/FSH ratio and 
lowest T (Supplementary Table S3).
Expression of JMJD1C and AR in tissues with different genotypes. In order to investigate the pos-
sible effect of the JMJD1C SNPs on JMJD1C and AR protein expression we performed immunohistochemical 
staining of testicular biopsies from men with different JMJD1C rs7910927 genotypes (6 TT, 6 TG and 5 GG). We 
observed that JMJD1C was primarily expressed in the nucleus of Sertoli and Leydig cells as well as germ cells until 
the round spermatid stage (see Supplementary Fig. S3). There was a slight tendency towards stronger staining of 
JMJD1C in biopsies originating from men with the TT genotype (see Supplementary Fig. S3). However, due to 
the nature of immunohistochemistry (IHC), as a semi-quantitative method, along with differences in fixation 
times of the biopsies, these results were not directly quantitatively comparable. No apparent differences in AR 
expression were observed between genotypes in the IHC experiments (evaluated by microscopy) and in all cases 
the AR protein was confined to the nuclei of Sertoli, Leydig and peritubular cells (see Supplementary Fig. S3).
Figure 1. Association between pubertal onset in boys and the JMJD1C SNP rs7910927. Median age at testis 
enlargement (≥4 mL) of boys from the COPENHAGEN Puberty study stratified by rs7910927 genotype. The 
model is adjusted for z-BMI scores. Standard errors depict the 5–95% confidence interval. Boys with the TT 
genotype entered puberty 3.6 months earlier than boys with the TG or GG genotypes.
www.nature.com/scientificreports/
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Discussion
In this study, we demonstrated that genetic variants related to JMJD1C were significantly associated with onset 
of puberty in boys, with a range of reproductive hormones (T, SHBG, FSH and Inhibin B) as well as testis size in 
adult men.
It is surprising that out of the large family of histone demethylases, JMJD1C appears to be modulating sev-
eral reproductive functions both in adolescence and adult life. Besides the associations identified in our study, 
other studies have demonstrated associations of JMJD1C SNPs with reduced testicular function9, reproductive 
hormones2,3, puberty10 as well as intracranial germ cell tumours12. No other histone demethylase shows the same 
Figure 2. Box-plots showing reproductive hormones, testis size, and total sperm count and potential 
associations with the JMJD1C SNP rs7910927 in the cohort of young men. The models and P-values are built 
on additive models. Associations between JMJD1C SNP rs7910927 and (a) FSH, (b) Inhibin B, (c) Inhibin B/
FSH ratio, (d) SHBG, (e) testosterone, (f) T x LH, (g) testis size by ultrasound, and (h) total sperm count. FSH 
and T x LH are presented on logarithmic scales; testosterone, SHBG, Inhibin B/FSH ratio, and total sperm count 
are presented on a cube root scale; and Inhibin B is presented on a square root scale in order to achieve normal 
distributions.
www.nature.com/scientificreports/
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number of associations with reproductive functions. Albeit a significant association with untransformed inhibin 
B levels was observed, the significance was lost after log-transformation for rs7910927. This could be due to differ-
ences in the distribution of inhibin B levels in men with different genotypes. The special link to reproductive func-
tion is, however, evident and may be due to the distinct feature of JMJD1C, which, besides its histone demethylase 
activity, most likely can interact directly with both the AR and the TR. Consequently, the impact of genetic 
variants in JMJD1C may have different effects in foetal and adult life or in different cell types depending on the 
exact location of the variants inside the JMJD1C gene (reviewed in Johansson et al.4). We speculate, that in cases 
where JMJD1C is engaged in histone demethylation, as described in rodent knockout studies9, it can be affected 
by genetic variants found in the JmjC-domain responsible for this function, but is not affected by variants in the 
AR or TR binding-domains. However, in cell types or developmental windows where the AR or TR is expressed, 
JMJD1C may also be engaged in co-activation of these receptors. In such cases, genetic variants in AR and TR 
binding-domains may influence the receptor activation and not the histone demethylase activity. Despite that the 
variants investigated in our study, are found outside the coding region of JMJD1C, they might affect JMJD1C pro-
moters or enhancers only effective under certain conditions. However, with the potential co-activation of both the 
AR and TR, it is likely that the effects on reproductive hormones are mediated through an effect on Sertoli cells. 
We found that JMJD1C was expressed in the testis and primarily confined to the nucleus of Sertoli and Leydig 
cells as well as germ cells until the round spermatid-stage. Moreover, the highly significant association with SHBG 
might be different from direct effects on the hypothalamic-pituitary-gonadal axis (HPG-axis), as SHBG is not 
produced in the testes or brain but in the liver. Future studies are needed to dissect the possible functional roles 
of JMJD1C in reproductive tissues.
The TT genotypes of both JMJD1C SNPs seem to be associated with the most optimal testicular function. The 
carriers of this genotype have lower FSH but higher Inhibin B levels, indicating that their Sertoli cells respond bet-
ter to FSH and do not need as much stimulation to support their function. Furthermore, since the men have lower 
T and SHBG (and a tendency to lower LH) we speculate that this could be due to their Sertoli cells being more 
sensitive to T stimulation, producing higher amounts of inhibin B (significant for rs10822184) and consequently 
supporting spermatogenesis better. In support of this, men with the TT genotype had lower T x LH index than the 
other men, and this was not affected by BMI. Men with the TT genotype also had larger testes (significant for both 
SNPs) and a non-significant tendency towards higher total sperm count. Moreover, murine Jmjd1c-knockout 
models have shown an age-related decrease in spermatogenesis, which could indicate sub-optimal Sertoli cell 
function leading to a gradual loss of germ cells9. We speculate therefore that JMJD1C may play a role in the devel-
opment of human Sertoli cells.
In line with this hypothesis, we observed that boys with the TT genotype entered puberty 3.6 months ear-
lier. A previous study found that self-reported onset of puberty was connected to subsequent semen quality and 
reproductive hormones in healthy young men13. The study showed that men entering puberty earlier and later 
than their peers had poorer semen quality and smaller testes. Furthermore, their hormone profiles also differed 
compared to the men that entered puberty at the average time. We do not have longitudinal data on reproductive 
rs7910927 rs10822184
N
GG TG TT
P-value N
CC CT TT
P-valueMean Mean Mean Mean Mean Mean
FSH (U/L) 998 2.88 2.63 2.49 9.89e-03 996 2.88 2.63 2.46 5.29e-03
Inhibin B (pg/mL) 995 156.81 161.33 169.50 5.20e-02 993 155.54 162.23 169.95 2.77e-02
InhibinB/FSH ratio 995 59.29 66.14 72.84 1.54e-02 993 58.89 66.46 73.94 6.61e-03
LH (U/L) 998 3.68 3.60 3.45 1.98e-01 996 3.71 3.59 3.43 1.02e-01
Testosterone (nmol/L) 993 22.19 21.46 20.08 1.19e-03 991 22.18 21.52 19.88 2.29e-04
Testosterone/LH ratio 993 6.07 6.08 5.90 5.99e-01 991 6.02 6.11 5.88 4.99e-01
Testosterone x LH 993 81.04 75.90 68.14 4.29e-03 991 81.57 75.99 66.93 7.55e-04
cFT (pmol/L) 991 470.71 472.79 461.50 6.42e-01 989 472.43 475.03 456.10 2.88e-01
cFT/LH ratio 991 136.28 144.82 144.26 3.45e-01 989 137.05 145.37 143.05 3.93e-01
Estradiol (pmol/L) 997 87.07 86.15 83.93 4.59e-01 995 87.64 85.51 84.21 3.96e-01
Testosterone/Estradiol ratio 993 273.36 281.35 263.2 3.20e-01 991 271.17 284.79 260.33 1.26e-01
cFT/Estradiol ratio 991 5.81 6.19 6.01 3.35e-01 989 5.79 6.27 5.94 1.46e-01
SHBG (nmol/L) 996 34.75 32.22 28.99 1.02e-08 994 34.54 32.1 29.01 2.58e-08
Semen volume (mL) 964 3.43 3.28 3.36 3.15e-01 964 3.45 3.25 3.38 1.01e-01
Sperm concentration (millions) 967 41.31 42.36 46.89 2.86e-01 967 41.31 42.73 46.73 3.84e-01
Total sperm count (millions) 963 139.88 134.93 156.68 1.22e-01 963 141.01 135.01 156.50 1.46e-01
Morphologically normal sperm (%) 953 6.85 7.19 7.42 4.29e-01 953 6.92 7.23 7.45 4.65e-01
Motile sperm (AB) (%) 934 56.22 54.49 53.87 2.66e-01 933 56.47 54.31 53.95 1.53e-01
Testis size (orchidometer) (mL) 999 19.94 20.41 21.03 3.25e-02 997 20.05 20.34 21.05 4.71e-02
Testis size (ultrasound) (mL) 995 13.15 13.58 14.05 2.55e-02 994 13.20 13.54 14.09 2.44e-02
Table 2. JMJD1C SNPs and reproductive parameters in young men. Associations between rs7910927 and 
rs10822184 and male reproductive parameters in young men assuming additive genetic models. N: number of 
men. Values are geometric mean values. P-values below 0.05 are considered significant and are marked in bold.
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parameters from the boys from the COPENHAGEN puberty study and the JMJD1C genotype did not change 
pubertal onset enough for the boys to be categorized as entering early or late. We nevertheless believe that there 
might be a connection between the earlier pubertal onset in the boys with the TT genotype and the potential 
better testicular function observed among young men with the TT genotype.
Conclusion
Genetic variations near the histone demethylase JMJD1C locus significantly affect pubertal onset in boys as well 
as circulating levels of several reproductive hormones and testis size in adult men. How JMJD1C functionally 
mediates these effects remains to be elucidated.
Methods
Study populations. We included 671 boys and adolescents from the COPENHAGEN puberty study, 1,027 
young Danish men representative of the general population, 315 fertile men, and 252 infertile men.
The COPENHAGEN puberty study. Participants were recruited as part of two population-based cohort 
studies of healthy Danish children and adolescents. Detailed information about the study has been published 
previously14. The COPENHAGEN Puberty Study14,15 (ClinicalTrials.gov ID: NCT01411527) is a cross-sectional 
study that has been conducted at ten schools in the Copenhagen area between 2006–2014. A total of 3,101 boys 
were invited to join the study, of which 767 boys were examined (overall participation rate, 25%). The boys with 
DNA available (n = 671) were included in the present study. Physical examinations of the boys included pubertal 
staging of genital development according to Tanner’s classification and testicular volume16. Testicular volume of 
4 mL and above (at least one testis) was considered to be a marker of pubertal onset.
Young men from the general population. Young Danish men 18–25 years of age were invited to partic-
ipate in a study of testicular function. The men answered a comprehensive questionnaire, underwent a physical 
examination, delivered a semen sample, and had a blood sample drawn. More information about the cohort and 
a description of exclusion criteria can be seen in Supplementary Materials and Methods and Supplementary 
Fig. S1B. The young men represent the general population and were recruited without any prior knowledge about 
their fertility status and thereby they represent both fertile and infertile men.
Fertile men. The group of fertile men comprised two groups examined at the Department of Growth and 
Reproduction; one examined in 1996–1998, which has been described previously17 and the other investigated 
in 2012–2014 following the same protocol. For both study periods, the men were invited to participate in the 
study when their female partners were examined routinely during the second trimester of their pregnancy. The 
men were invited to the study if they were born and raised in Denmark, resided in the local referral area, were 
20–45 years of age, and the current pregnancy was achieved by natural conception (i.e. not the result of fertility 
treatment). They underwent an examination program similar to that described for the men from the general 
population including a similar questionnaire. Exclusion criteria are described in Supplementary Materials and 
Methods and Supplementary Fig. S1B.
Infertile men. The group of infertile patients consisted of 405 infertile men who had been examined for 
male infertility in the out-patient clinic at the Department of Growth and Reproduction, Copenhagen University 
Hospital, Denmark, in 2013 and 2014. During their work-up, the men delivered one or two semen samples for 
analysis and they had a blood sample drawn at the first visit. For more information and a description of exclusion 
criteria see Supplementary Materials and Methods and Supplementary Fig. S1.
Semen samples. All adult men provided a semen sample by masturbation in a room close to the semen 
laboratory. The semen analysis is thoroughly described in Jørgensen et al.18. Analyses performed included volume 
measurement and assessment of sperm concentration, total sperm count, motile sperm cells, and morphologi-
cally normal sperm cells. Furthermore, the abstinence time was noted.
Reproductive hormone profiles. Blood samples were drawn between 0800 h and 1400 h. Hormone meas-
urements of the infertile men were performed immediately following blood sampling. Blood samples from the 
peri-pubertal boys, the young men and fertile men were centrifuged and serum frozen at −20 °C until analysed 
in batches.
Serum levels of FSH, LH, SHBG, T, estradiol, and Inhibin B were determined by immuno-based techniques 
as described in19. Free T (cFT) was calculated on the basis of the measured serum concentrations of total T and 
SHBG using the method of Vermeulen et al.20 and a fixed albumin concentration of 43.8 g/L.
Reproductive hormones (the same as mentioned above) in blood samples from boys from the COPENHAGEN 
puberty study were analysed with similar methods as described by Busch et al.21.
Genotyping. EDTA-preserved peripheral blood was used for isolation of genomic DNA using SEV AS1010 
DNA purification kits on a Maxwell 16-MDx instrument (Promega, Madison, WI, USA). The DNA concentration 
was quantified on a NanoDrop ND-1000 spectrophotometer (Saveen Werner, Limhamn, Sweden). The DNA 
samples were analysed using the KASPTM SNP genotyping assays specific for the two JMJD1C SNPs rs7910927 
and rs10822184. A thorough description of the method can be found in Supplementary Materials and Methods.
Immunohistochemistry. Seventeen testis tissue samples from the archives of Department of Growth and 
Reproduction were used for immunohistochemistry (IHC) with antibodies against JMJD1C and the androgen 
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receptor. These samples were biopsies taken from the contralateral testicle from patients orchiectomised because 
of germ cell neoplasia in situ (GCNIS) or invasive testis cancer. Only biopsies, without GCNIS or any other 
pathology were selected for the study, and all specimens had normal histology and tubules with complete sper-
matogenesis. The biopsies were obtained from the surgery departments at different times of the day, so the tissue 
fixation time varied, which could influence the quality of the tissue. Moreover, DNA originating from blood 
samples of the same patients was available and genotyping for the JMJD1C SNP rs7910927 revealed 6 TT, 6 TG 
and 5 GG specimens. IHC was performed as previously described22. Antigen retrieval was conducted with a 
pressure cooker (Biocare medical decloaking chamber, Concord, CA, USA) in TEG buffer (10 mM Tris, pH 8.5). 
The JMJD1C monoclonal mouse anti-human antibody (WHO221037M3, Sigma Aldrich, Saint Louis, MO, USA) 
was used in dilution 1:2,500 (0.2 μg/ml) and the monoclonal mouse anti-human androgen receptor antibody 
(MS-443-p, ThermoFisher Scientific, MI, USA) was diluted 1:100 (2 μg/ml). Peroxidase reaction development 
was performed with diaminobenzidine which resulted in a brown colour.
Data processing and statistical analyses. Hardy-Weinberg equilibrium as well as associations between 
single SNPs and reproductive parameters were analysed by use of the R package ‘SNPassoc’23. All analyses were 
built on additive (codominant) genetic models unless otherwise stated. Linkage disequilibrium was calculated by 
use of the R package ‘Genetics’24.
Statistical analyses of pubertal timing (COPENHAGEN puberty study) was performed by use of the statistical 
software SAS (Probit analysis: proc lifereg) version 9.4 (SAS Institute, Inc). Detailed information about the proc 
lifereg procedure has been given previously21. In the analysis, age at pubertal onset was adjusted for BMI z-score 
WHO age-specific body mass index scores25. If longitudinal data was available, a mean of all individual BMI 
z-scores was calculated.
The T/LH and Inhibin B/FSH ratios as well as T x LH were calculated. Most of the data was transformed to 
achieve normal distribution: Inhibin B/FSH ratio, T, T/LH, cFT, SHBG, semen volume, sperm concentration, and 
total sperm count by cubic root transformation; FSH, LH, and T x LH by log transformation, and Inhibin B and 
estradiol by square root transformation.
The following confounders were included in the analyses; FSH, LH, Inhibin B, and SHBG were adjusted for 
BMI and time of blood sampling; T and estradiol were adjusted for BMI, time of blood sampling and smok-
ing. Semen parameters (volume, concentration, total sperm count and morphology) for the young men were 
adjusted for abstinence time (divided into three variables – below 24 h, 24–96 h and above 96 h), fever, cryptor-
chidism, presence of varicocele, previous infections in the epididymis, smoking, hash smoking (except in the 
fertile cohort), and maternal smoking during pregnancy. Sperm motility was, in addition to the above-mentioned 
confounders, also adjusted for the time from sample delivery to semen analysis. For the infertile men, semen 
parameters were adjusted for the same parameters as for the young men except from maternal smoking during 
pregnancy due to lack of information about this.
Ethical Approval. The study was approved by the Ethical Committee of the Capital Region of Denmark 
(H-KF-289428, H-KF-282214, H-4-2010-138, 2012-41-1390, H-16019637). The study was conducted in accord-
ance with the Helsinki II Declaration. All men received written information and informed consent was obtained 
from all participants. All boys from the COPENHAGEN Puberty Study and their parents received written infor-
mation and informed consent was obtained.
Data availability. The datasets analysed during the current study are not publicly available due to Danish 
ethical rules on human pseudo anonymous data protecting the privacy of cohort participants. To meet require-
ments of reproducibility we provide two files (Supplementary Files 1 and 2) with genotypes and their link to 
single endpoints. The order of the genotypes (individuals) has been scrambled between each endpoint.
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